Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy.
Saved in:
| Title: | Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy. |
|---|---|
| Authors: | Wu SG; Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China., Hong SS; Department of Obstetrics and Gynecology, Quan Zhou Women's and Children's Hospital, Quanzhou, People's Republic of China., Tang YL; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China., Zhou J; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China. Electronic address: zhoujuan@xmu.edu.cn. |
| Source: | European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2026 May; Vol. 321, pp. 115045. Date of Electronic Publication: 2026 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41780138 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+SG%22">Wu SG</searchLink>; Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Hong+SS%22">Hong SS</searchLink>; Department of Obstetrics and Gynecology, Quan Zhou Women's and Children's Hospital, Quanzhou, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Tang+YL%22">Tang YL</searchLink>; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, People's Republic of China. Electronic address: zhoujuan@xmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375672%22">European journal of obstetrics, gynecology, and reproductive biology</searchLink> [Eur J Obstet Gynecol Reprod Biol] 2026 May; Vol. 321, pp. 115045. <i>Date of Electronic Publication: </i>2026 Feb 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>0375672 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7654 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203012115%22">03012115 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Obstet Gynecol Reprod Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41780138 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejogrb.2026.115045 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115045 Titles: – TitleFull: Survival trends among patients with newly diagnosed stage IVB cervical cancer before and after the approval of bevacizumab and immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu SG – PersonEntity: Name: NameFull: Hong SS – PersonEntity: Name: NameFull: Tang YL – PersonEntity: Name: NameFull: Zhou J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1872-7654 Numbering: – Type: volume Value: 321 Titles: – TitleFull: European journal of obstetrics, gynecology, and reproductive biology Type: main |
| ResultId | 1 |